SecBot SecBot
8-K ·Filed Jul 17, 2026

CNTN

Canton Strategic Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001493152-26-033664
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

This is a routine governance filing with no trading implications. Monitor future filings for any material operational or financial updates.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
CNTN ▼ -8.26% at T+60d
NEUTRAL call -8.26% · α vs SPY -12.94% · entry $2.30 → $2.11
Entry = T+0 close
Jul 17, 2026
via day close
T+1d
-10.87%
call -10.87% · α -10.71%
$2.05
settled 3mo ago
T+5d
-10.43%
call -10.43% · α -9.75%
$2.06
settled 3mo ago
T+20d
-12.17%
call -12.17% · α -16.62%
$2.02
settled 3mo ago
T+60d
-8.26%
call -8.26% · α -12.94%
$2.11
settled 16d ago

Price Chart

Loading chart...

Executive Summary

Canton Strategic Holdings filed an 8-K reporting results from its 2026 annual meeting of stockholders held on July 13, 2026. All seven director nominees were elected, and the appointment of Rosenberg Rich Baker Berman P.A. as independent auditor for FY 2026 was ratified. The filing also notes the post-meeting election of board committee assignments. This is a routine governance filing with no material financial or operational impact on the company.

Key Facts

  • Annual meeting held July 13, 2026; quorum of 25,792,741 shares (33.4% of 77,122,584 outstanding) was present.
  • All seven director nominees (Mark Wendland, Clay Kahler, Jill E. Sommers, William Wiley, Sean Galvin, Pamela L. Carter, Rishi Nangalia) were elected with overwhelming support (over 25.4 million votes 'for' each).
  • Appointment of Rosenberg Rich Baker Berman P.A. as independent auditor for FY 2026 was ratified with 25,780,986 votes 'for'.
  • Board committees were elected on July 15, 2026: Audit (Chair: Sean Galvin), Compensation (Chair: William Wiley), Nominating and Governance (Chair: Jill E. Sommers).

Financial Impact

No financial impact disclosed in this filing.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-033664
Document: 0001493152-26-033664-index-headers.html0001493152-26-033664
Document: 0001493152-26-033664-index.html0001493152-26-033664
Document: 0001493152-26-033664.txt0001493152-26-033664
11 reports for CNTN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CNTN — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G
NEUTRAL ★ 4/10
$1.93awaiting T+60—$1.91 (−1.04%)
Oct 14, 2026
13d ago
Press Release
NEUTRAL ★ 3/10
$1.84awaiting T+60—$1.91 (+4.09%)
Sep 22, 2026
5w ago
Institutional Cluster
NEUTRAL ★ 3/10
$2.45awaiting T+60—$1.91 (−22.04%)
Aug 14, 2026
10w ago
8-K
MIXED ★ 5/10
$2.03awaiting T+60—$1.91 (−5.68%)
Aug 14, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$2.02awaiting T+60—$1.91 (−5.45%)
Jul 23, 2026
13w ago
8-K
BULLISH ★ 5/10
$2.06 $1.87▼ −9.22%▼ −13.78%$1.91 (−7.28%)
Jul 17, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$2.30 $2.11▼ −8.26%▼ −12.94%$1.91 (−16.96%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$2.30 $2.11▼ −8.26%▼ −12.94%$1.91 (−16.96%)
Jul 15, 2026
14w ago
3
NEUTRAL ★ 2/10
$2.34 $2.11▼ −9.83%▼ −13.54%$1.91 (−18.38%)
Jul 15, 2026
14w ago
3
NEUTRAL ★ 2/10
$2.34 $2.11▼ −9.83%▼ −13.54%$1.91 (−18.38%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 9h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 17, 2026